Understand the source comparison
Peptides and Rapamycin Synergy Timing Protocol: Full-Spectrum Comparison
| Dosing Strategy | Rapamycin Timing | Peptide Timing | mTOR Suppression Window | Autophagy Markers (LC3-II:I Ratio) | Anabolic Signaling (p70S6K Activity) | Practical Outcome ||—|—|—|—|—|—|| Simultaneous (both AM) | 8 AM | 8 AM | Partial, contested | Moderate
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Dosing Strategy | Rapamycin Timing | Peptide Timing | mTOR Suppression Window | Autophagy Markers (LC3-II:I Ratio) | Anabolic Signaling (p70S6K Activity) | Practical Outcome ||—|—|—|—|—|—|| Simultaneous (both AM) | 8 AM | 8 AM | Partial, contested | Moderate (1.8–2.2×) | Reduced 30–50% vs peptide-only | Metabolic interference. Neither pathway fully engaged || Simultaneous (both PM) | 8 PM | 8 PM | Partial, contested | Moderate (1.9–2.3×) | Reduced 35–55% vs peptide-only | Same as AM. Timing doesn't resolve the conflict || Sequential (standard protocol) | 8 PM | 8 AM next day | Full, uncontested | High (3.2–4.1×) | Normal 95–105% vs peptide-only | Both pathways fully active at different times. No interference || Extended separation | 8 PM | 2 PM next day | Full, uncontested | High (3.1–3.9×) | Normal 98–110% vs peptide-only | Slight improvement in anabolic response, minimal autophagy difference || Inverted (rapamycin AM) | 8 AM | 8 PM same day | Moderate, misaligned | Low (1.5–2.0×) |